In what patient populations would you consider using disulfiram (Antabuse) instead of or in addition to acamprosate or naltrexone? In your experience, do any clinical or psychosocial characteristics predict better outcomes with disulfiram? How do you approach informed consent and patient education about the risks of disulfiram?